Diazepam (Valium)
Pronunciation: dye-AZ-eh-pam.
- Generic name
- diazepam
- Drug class
- Benzodiazepine (anxiolytic / sedative-hypnotic / anticonvulsant / muscle relaxant)
- Form
- Tablet (commonly 2 mg, 5 mg, 10 mg), oral solution, rectal gel/solution, and injectable solution, depending on market and manufacturer
- Route
- Oral (tablet, oral solution), rectal (gel/solution), or injection (IV/IM), depending on formulation and indication
- Legal status
- Prescription-only, controlled substance (Schedule IV in the US federal Controlled Substances Act; Schedule 4 Prescription Only Medicine in Australia)
Availability and supply rules vary by country
Trade names by country: United States · United Kingdom · Canada · Australia · New Zealand
Australia: Valium; generic diazepam (Diazepam WGR, Diazepam Apo) (5) · Full directory
Boxed warning: Risks from concomitant use with opioids; and risks of abuse, misuse, addiction, physical dependence, and life-threatening withdrawal reactions
Diazepam carries a boxed warning (the US FDA's strongest safety warning), added to all benzodiazepine labels, with three distinct parts. First: concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death; reserve concomitant prescribing for patients with no adequate alternative treatment options, and limit dosages and durations to the minimum required. Second: the use of benzodiazepines, including diazepam, exposes users to risks of abuse, misuse, and addiction, which can lead to overdose or death; abuse and misuse commonly involve concomitant use of other medicines, alcohol, and/or illicit substances, which increases the risk of serious harm. Third: continued use of diazepam may lead to clinically significant physical dependence; abrupt discontinuation or a rapid dose reduction, or administration of flumazenil (a benzodiazepine antagonist) to a physically dependent patient, may precipitate acute withdrawal reactions, including seizures, which can be life-threatening. Because of these genuine risks, diazepam dose changes, tapering, and stopping must always be planned and supervised by your prescriber, never carried out on your own. (1)
What diazepam is and how it works
Diazepam (brand name Valium) is a prescription benzodiazepine medicine used for short-term relief of anxiety, certain muscle spasms, some seizure disorders, acute alcohol withdrawal symptoms, and premedication before some procedures. (1)
Diazepam carries a genuine, current boxed warning -- the FDA's strongest safety warning -- covering three real risks: dangerous, potentially fatal breathing problems if combined with opioids; risk of abuse, misuse, and addiction; and risk of physical dependence with life-threatening withdrawal reactions if stopped abruptly or the dose is reduced too quickly. Because of these risks, diazepam is intended for short-term use, and any change in dose or plan to stop must always be made together with your prescriber -- never on your own.
Mechanism of action: how diazepam works
Diazepam is a benzodiazepine that enhances the effect of GABA (gamma-aminobutyric acid), the brain's main inhibitory neurotransmitter, at the GABA-A receptor, producing anxiolytic, sedative, muscle-relaxant, and anticonvulsant effects. (1) (2)
What diazepam is used for
Short-term relief of anxiety
Used for the short-term relief of anxiety that is severe, disabling, or causing unacceptable distress -- in UK/New Zealand sources, this use is specifically capped at 2-4 weeks. (1) (2) (6)
Acute alcohol withdrawal
Used for the symptomatic relief of acute alcohol withdrawal, including agitation, tremor, impending or acute delirium tremens, and hallucinosis. (1) (5)
Muscle spasm
Used as an adjunct for relief of skeletal muscle spasm, including spasm associated with local pathology or conditions such as cerebral palsy. (1) (2)
Seizure/convulsive disorders (adjunctive)
Used as adjunctive therapy in certain convulsive/seizure disorders. (1) (2)
Premedication before procedures
Used in some markets as premedication to relieve anxiety and tension before surgical or other procedures. (2)
Before taking diazepam
Do not take / not appropriate for
- Do not take diazepam if you have myasthenia gravis, severe breathing problems (severe respiratory insufficiency), severe liver problems (severe hepatic insufficiency), sleep apnea syndrome, or acute narrow-angle glaucoma. (all countries) (1)
- Do not give diazepam to infants under 6 months of age. (all countries) (1)
- Do not combine diazepam with opioid medicines unless your prescriber has specifically decided there is no adequate alternative, because of the real risk of profound sedation, dangerously slowed breathing, coma, and death. (all countries) (1)
- Do not stop diazepam abruptly or reduce your dose quickly on your own after regular use, because of the real risk of life-threatening withdrawal reactions, including seizures. (all countries) (1) (2)
Tell your clinician about
- Any personal or family history of alcohol or drug misuse, since this increases the risk of abuse, misuse, and addiction with diazepam.
- All other medicines you take, especially opioids, other sedatives, or anything affecting breathing.
- Any history of liver or kidney problems, breathing problems, or glaucoma.
- Whether you are pregnant, planning pregnancy, or breastfeeding.
- How long you have been taking diazepam before considering any dose change, since even short-term use can lead to some dependence.
How to take diazepam
- Take diazepam exactly as your prescriber directs, for the shortest time needed -- current UK/New Zealand guidance caps the anxiety-relief use at about 2-4 weeks.
- Before starting, your prescriber should discuss a plan for how treatment will eventually end, to help reduce the risk of dependence.
- Never change your own dose, stop abruptly, or take diazepam more often or in a larger amount than prescribed -- this is central to both the addiction/misuse risk and the withdrawal risk described in the boxed warning.
- If your prescriber decides it is time to stop diazepam after regular use, they will typically taper (gradually reduce) your dose over time rather than stopping it suddenly.
Procedures and treatment changes
Tell the treating team before surgery, procedures, or any medicine change. Do not alter treatment without the responsible clinician. (1) (2) (3) (4) (5) (6) (7)
Missed dose
Contact your prescriber or pharmacist for guidance if you miss a dose. Do not take an extra dose to make up for a missed one, and do not change your overall dosing pattern on your own.
Overdose
Seek emergency medical help immediately for a suspected overdose, especially if diazepam has been combined with opioids, alcohol, or other sedatives, or if there are signs of severe drowsiness, confusion, slowed or stopped breathing, or loss of consciousness. Overdose risk and severity are substantially increased when diazepam is combined with opioids or alcohol. (1)
Side effects
Side effects and their urgency vary; report severe, persistent, or concerning symptoms.
Drowsiness and fatigue.
What to notice: Drowsiness and fatigue.
What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (1)
Muscle weakness (ataxia).
What to notice: Muscle weakness (ataxia).
What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (1)
Dizziness.
What to notice: Dizziness.
What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (2)
Confusion, particularly in older adults.
What to notice: Confusion, particularly in older adults.
What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (2)
Serious warnings
Signs of dangerous breathing problems, especially if combined with opioids — boxed_warning
Symptoms: Severe drowsiness, slow or shallow breathing, blue-tinged lips or fingertips, extreme difficulty waking up, or loss of consciousness.
Action: Seek emergency medical help immediately -- combining diazepam with opioids can cause profound sedation, dangerously slowed breathing, coma, and death, particularly at the start of combined treatment or after a dose increase. (1)
Signs of abuse, misuse, or developing addiction — boxed_warning
Symptoms: Taking diazepam more often, in a higher amount, or for longer than prescribed; strong urges to keep using it; using it together with alcohol or illicit substances.
Action: Talk to your prescriber promptly -- diazepam carries a genuine, boxed-warning-level risk of abuse, misuse, and addiction, which can lead to overdose or death, and this risk is higher when combined with alcohol or other substances. (1)
Signs of withdrawal after stopping or reducing the dose — boxed_warning
Symptoms: Anxiety, tremor, sweating, insomnia, confusion, or seizures after stopping diazepam or lowering the dose, especially if done abruptly.
Action: Seek urgent medical help for seizures or severe withdrawal symptoms -- abrupt discontinuation or rapid dose reduction of diazepam can cause acute withdrawal reactions that can be life-threatening. Any change in dose or plan to stop must be directed by your prescriber, typically with a gradual, stepwise dose reduction, never abrupt self-directed stopping. (1) (2) (4)
Signs of a serious allergic reaction — emergency
Symptoms: Swelling of the face, lips, tongue, or throat; difficulty breathing; widespread rash or hives.
Action: Seek emergency medical help immediately. (1)
Interactions
- Opioid pain or cough medicines: combining with diazepam carries a genuine, boxed-warning-level risk of profound sedation, dangerously slowed breathing, coma, and death. (1)
- Alcohol: increases sedation and breathing-suppression risk, and increases the risk of misuse-related harm. (1)
- Other sedatives, sleep medicines, or muscle relaxants can add to diazepam's sedating and breathing-suppression effects. (2)
- Flumazenil (a benzodiazepine antagonist, sometimes used in overdose) may precipitate acute, potentially life-threatening withdrawal reactions, including seizures, in someone who is physically dependent on diazepam. (1)
Pregnancy, breastfeeding, kidney/liver function, age
Pregnancy
Discuss with your prescriber -- benzodiazepine use in pregnancy requires individualised specialist risk-benefit assessment; do not stop or start diazepam in pregnancy without medical guidance. (1) (2) (3) (4) (5) (6) (7)
Breastfeeding
Discuss with your prescriber before use while breastfeeding. (1) (2) (3) (4) (5) (6) (7)
Children
Contraindicated under 6 months of age; other paediatric use is specialist-directed and indication-specific. (1) (2) (3) (4) (5) (6) (7)
Elderly
Confusion and increased sedation are more common in older adults; your prescriber may use a lower starting dose and monitor more closely. (1) (2) (3) (4) (5) (6) (7)
Hepatic_impairment
Contraindicated in severe hepatic insufficiency; use in milder liver impairment requires caution and closer monitoring, since diazepam is metabolised by the liver. (1) (2) (3) (4) (5) (6) (7)
Renal_impairment
Not specifically quantified as a hard contraindication in the sources reviewed for this dossier, but your prescriber will consider your overall clinical picture. (1) (2) (3) (4) (5) (6) (7)
Source_ids
US-DAILYMED-VALIUM-2026,UK-EMC-DIAZEPAM-SMPC-2026 (1) (2) (3) (4) (5) (6) (7)
Monitoring
Before starting
- Personal/family history of substance misuse
- Current use of opioids or other sedatives
- Liver function and breathing status
- A discussion of the treatment duration and end-of-treatment plan
During treatment
- Regular review of ongoing need, given the short-term intent of most indications.
- Watch for signs of tolerance, misuse, or dependence developing, even with short-term use.
- If stopping after regular use, dose is typically tapered gradually under your prescriber's direction rather than stopped abruptly.
Storage
Store at controlled room temperature, in the original container with a child-resistant closure, out of reach of children, and away from anyone who might misuse it. Dispose of unused diazepam through a medicine take-back program where available, given its abuse/misuse potential.
Study the drug class: Benzodiazepines
Professional information
Clinician-facing context only, sourced from the current US FDA Valium prescribing information and UK SmPC, plus Canada/Australia/New Zealand regulator sources reviewed for this dossier; verify against the current full label before prescribing.
United States
Indication: Anxiety, muscle spasm, adjunctive seizure treatment
Dose summary: 2-10 mg, 2-4 times daily (anxiety/seizures) or 3-4 times daily (muscle spasm), individualised.
Renal context: No specific hard adjustment described in sources reviewed; hepatic impairment (severe) is contraindicated. (1)
United Kingdom / New Zealand
Indication: Short-term anxiety relief
Dose summary: Individualised dosing, duration capped at 2-4 weeks for the anxiety indication specifically.
Renal context: No specific adjustment described in sources reviewed. (2) (6)
Hepatic guidance
Contraindicated in severe hepatic insufficiency; diazepam is hepatically metabolised (partly to active metabolites, e.g. desmethyldiazepam), so impaired liver function can prolong its effects.
Overdose note
Flumazenil may be used in hospital to reverse benzodiazepine effects in overdose, but can precipitate acute, potentially life-threatening withdrawal/seizures in a physically dependent patient -- use requires specialist judgement, particularly when opioids or other substances are also involved. (1) (2)
Frequently asked questions
Does diazepam (Valium) have a boxed warning?
Yes -- a real, current, three-part FDA boxed warning applies to all benzodiazepines, including diazepam: (1) combining it with opioids can cause profound sedation, dangerously slowed breathing, coma, and death; (2) it carries a genuine risk of abuse, misuse, and addiction that can lead to overdose or death; (3) continued use can cause physical dependence, and stopping abruptly or reducing the dose too quickly can cause acute, potentially life-threatening withdrawal reactions, including seizures. (1)
Can I stop taking diazepam on my own if I feel better?
No -- you should never stop diazepam abruptly or change your dose on your own after taking it regularly, even for a relatively short time. Doing so can cause a withdrawal reaction that can include seizures and can be life-threatening. Your prescriber will typically taper your dose down gradually, in a stepwise way, rather than stopping it suddenly. (1) (2)
Why is diazepam usually only prescribed short-term?
Because of the genuine risk of dependence, tolerance, and withdrawal, which can develop even with short-term use. UK and New Zealand product information specifically caps the anxiety-relief use at about 2-4 weeks, and current safety guidance (including a 2022 New Zealand Medsafe reminder to prescribers) continues to emphasise these real, current risks. (2) (7)
Are 'diazepam', 'Valium', and 'Wyeth Diazepam' different medicines?
No -- they are the same active ingredient and medicine. This page is catalogued under 'Wyeth Diazepam' as its canonical record; other catalogue entries for 'diazepam' and 'Valium' are the same medicine and redirect here. (1)
References
- VALIUM (diazepam) tablet -- full prescribing informationU.S. Food and Drug Administration / DailyMed (NIH), full prescribing information · United States · accessed 2026-07-30 · source 1
- Diazepam Tablet (2 mg / 5 mg / 10 mg) -- Summary of Product Characteristicselectronic medicines compendium (emc), United Kingdom · United Kingdom · accessed 2026-07-30 · source 2
- Diazepam -- list of nationally authorised medicinal products (PSUSA/00001029/202503)European Medicines Agency (EMA) -- Periodic Safety Update Report Single Assessment (PSUSA) list of nationally authorised medicinal products · European Union · accessed 2026-07-30 · source 3
- VALIUM (diazepam) / generic diazepam tablets -- Health Canada Product MonographHealth Canada product monograph · Canada · accessed 2026-07-30 · source 4
- VALIUM (diazepam) 5 mg tablet -- TGA-approved Product Information / ARTG entry 48566Therapeutic Goods Administration (TGA), Australia, via the Australian Commission on Safety and Quality in Health Care's Medicine Finder · Australia · accessed 2026-07-30 · source 5
- Diazepam -- New Zealand Data Sheet(s) (Arrow-Diazepam, DBL Diazepam injection, and others)Medsafe (New Zealand Medicines and Medical Devices Safety Authority) · New Zealand · accessed 2026-07-30 · source 6
- Reminder: Potential for abuse, dependence and withdrawal with benzodiazepines (June 2022)Medsafe (New Zealand Medicines and Medical Devices Safety Authority) -- Prescriber Update safety communication · New Zealand · accessed 2026-07-30 · source 7
Brand names by country
Single-ingredient diazepam names are shown separately by country. Product availability, strengths, and supply rules can change; combination products are not included here.
Priority countries
United States
- Valium2 mg, 5 mg, 10 mg · waylis therapuetics llc
- Valtoco10 mg/.1mL, 5 mg/.1mL, 7.5 mg/.1mL · neurelis, inc
- Diazepam Intensol5 mg/mL · hikma pharmaceuticals usa inc.
United Kingdom
- Diazepam (generic; Valium historically) (2)MHRA licensed emc smpc confirmed · 2 mg, 5 mg, 10 mg tablet · multiple UK generic manufacturers
Canada
- VALIUM
- DIASTAT
- DIAZEPAM INJECTION SDZ
Australia
- Valium; generic diazepam (Diazepam WGR, Diazepam Apo) (5)TGA ARTG registered 1994-05-17 confirmed · 5 mg tablet · Atnahs Pharma Australia Pty Ltd and other suppliers
New Zealand
- Arrow-Diazepam, DBL Diazepam injection, and other registered brands (6)Medsafe datasheets confirmed multiple brands · 2 mg, 5 mg tablet, 10mg/2mL injection · multiple NZ-registered suppliers
View brands in additional countries.
European Union
Diazepam (generic; nationally authorised per member state) (3)